Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 04, 2023

SELL
$238.39 - $265.32 $581,671 - $647,380
-2,440 Reduced 40.59%
3,571 $942,000
Q1 2023

May 10, 2023

SELL
$229.71 - $259.35 $626,878 - $707,766
-2,729 Reduced 31.22%
6,011 $1.49 Million
Q4 2022

Feb 09, 2023

SELL
$218.29 - $256.91 $10,914 - $12,845
-50 Reduced 0.57%
8,740 $2.22 Million
Q3 2022

Nov 10, 2022

SELL
$51.03 - $264.23 $1,224 - $6,341
-24 Reduced 0.27%
8,790 $1.96 Million
Q2 2022

Aug 12, 2022

BUY
$234.74 - $275.42 $35,445 - $41,588
151 Added 1.74%
8,814 $2.17 Million
Q1 2022

May 13, 2022

SELL
$243.64 - $270.48 $275,069 - $305,371
-1,129 Reduced 11.53%
8,663 $2.3 Million
Q4 2021

Feb 09, 2022

SELL
$230.08 - $250.94 $329,244 - $359,095
-1,431 Reduced 12.75%
9,792 $2.46 Million
Q3 2021

Nov 12, 2021

SELL
$232.72 - $256.47 $323,015 - $355,980
-1,388 Reduced 11.01%
11,223 $2.76 Million
Q2 2021

Aug 13, 2021

SELL
$232.65 - $254.58 $589,302 - $644,851
-2,533 Reduced 16.73%
12,611 $3.07 Million
Q1 2021

May 14, 2021

SELL
$232.09 - $256.88 $1.07 Million - $1.18 Million
-4,613 Reduced 23.35%
15,144 $3.68 Million
Q4 2020

Feb 12, 2021

BUY
$221.92 - $245.94 $163,776 - $181,503
738 Added 3.88%
19,757 $4.94 Million
Q3 2020

Nov 13, 2020

BUY
$215.77 - $276.76 $11,651 - $14,945
54 Added 0.28%
19,019 $4.43 Million
Q2 2020

Aug 12, 2020

SELL
$219.9 - $263.41 $55,194 - $66,115
-251 Reduced 1.31%
18,965 $4.54 Million
Q1 2020

May 11, 2020

BUY
$195.69 - $279.01 $1 Million - $1.43 Million
5,127 Added 36.39%
19,216 $4.42 Million
Q4 2019

Feb 12, 2020

BUY
$236.45 - $266.82 $1.13 Million - $1.28 Million
4,780 Added 51.35%
14,089 $3.83 Million
Q3 2019

Oct 24, 2019

BUY
$230.58 - $256.08 $2.15 Million - $2.38 Million
9,309 New
9,309 $2.36 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Pegasus Partners Ltd. Portfolio

Follow Pegasus Partners Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pegasus Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Pegasus Partners Ltd. with notifications on news.